Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

This study has been completed.
Sponsor:
Collaborators:
Naturalpha
Premier Research Group plc
Information provided by (Responsible Party):
Genfit
ClinicalTrials.gov Identifier:
NCT01694849
First received: September 24, 2012
Last updated: January 13, 2016
Last verified: January 2016